Press Release: Mymetics : Mymetics Corporation (MYMX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

( Mymetics Corporation (Mymetics) is a development stage biotechnology company. It carries out the development of mucosal and virosomes based vaccines that help prevent HIV (AIDS) from crossing the mucosal barriers, prevent malaria, respiratory syncytial virus (RSV), and influenza. The company's product pipeline includes five vaccines, namely, HIV-1 vaccine in Phase I clinical trial; RSV vaccine in preclinical phase; Herpes Simplex Virus (HSV) vaccine in preclinical phase; malaria vaccine completed Phase Ia clinical trial in humans with two antigens AMA-1 and CSP-1, and Phase Ib on children and adults; and Intranasal Influenza vaccine is in Phase I clinical trial. Along with ..

Read full article »

Top Competitors or Alternatives

Looks like nobody has added any competitors for Mymetics yet.

Missing a competitor? Contribute!

Annual Revenue
Ronald Kempers's photo - President & CEO of Mymetics

President & CEO

Ronald Kempers

CEO Approval Rating


Mymetics's headquarters is in Epalinges, Other. Mymetics has a revenue of $691.1K, and 1 employees. Mymetics has 4 followers on Owler.